MedTrace Logo

Study of Dronabinol Treatment for Depression and/or Anxiety in Older Patients

NCT03369639 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2019-07-31

No results posted yet for this study

Summary

This is an observational study evaluating the safety and efficacy of dronabinol for the treatment of anxiety and/or depression in older adults. Participants who are prescribed dronabinol as part of a voluntary inpatient stay in McLean's Division of Geriatric Psychiatry will be interviewed about their mood and cognition on a weekly basis while on dronabinol.

Conditions

  • Depression, Anxiety

Sponsors & Collaborators

  • Mclean Hospital

    lead OTHER

Principal Investigators

  • Brent P Forester, MD · Mclean Hospital

Eligibility

Min Age
50 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-28
Primary Completion
2018-10-01
Completion
2018-10-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03369639 on ClinicalTrials.gov